Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae

por Serio, Alisa W, Keepers, Tiffany, Krause, Kevin M
Publicado 2019

Effect of In Vitro Testing Parameters on Ceftazidime-Avibactam Minimum Inhibitory Concentrations

por Keepers, Tiffany R., Gomez, Marcela, Biek, Donald, Critchley, Ian, Krause, Kevin M.
Publicado 2015

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012

por Keepers, Tiffany R., Gomez, Marcela, Celeri, Chris, Krause, Kevin M., Biek, Donald, Critchley, Ian
Publicado 2017

124. Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the...

por Keepers, Tiffany R, Cebrik, Deborah S, Cloutier, Daniel J, Komirenko, Allison, Connolly, Lynn, Krause, Kevin
Publicado 2018

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection

por Nicklas, Danielle A., Maggioncalda, Emily C., Story-Roller, Elizabeth, Eichelman, Benjamin, Tabor, Chavis, Serio, Alisa W., Keepers, Tiffany R., Chitra, Surya, Lamichhane, Gyanu
Publicado 2022

Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis

por Karau, Melissa J., Schmidt-Malan, Suzannah M., Cunningham, Scott A., Mandrekar, Jayawant N., Pritt, Bobbi S., Keepers, Tiffany R., Serio, Alisa W., Chitra, Surya, Patel, Robin
Publicado 2022

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

por Madrid, Peter B., Chopra, Sidharth, Manger, Ian D., Gilfillan, Lynne, Keepers, Tiffany R., Shurtleff, Amy C., Green, Carol E., Iyer, Lalitha V., Dilks, Holli Hutcheson, Davey, Robert A., Kolokoltsov, Andrey A., Carrion, Ricardo, Patterson, Jean L., Bavari, Sina, Panchal, Rekha G., Warren, Travis K., Wells, Jay B., Moos, Walter H., Burke, RaeLyn L., Tanga, Mary J.
Publicado 2013